Vimarsana
Biggest News Aggregation in the World

Page 2 - Burnham Prebys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Burnham Prebys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Burnham Prebys Today - Breaking & Trending Today

La Jolla's Sanford Burnham Prebys adding six scientists in hopes of launching new era of collaboration - Vimarsana News

La Jolla's Sanford Burnham Prebys adding six scientists in hopes of launching new era of collaboration

The newcomers, brought in with help from a $70 million donation, are versed in different technologies that can be applied to any field, the medical research institute's leader says

La Jolla's Sanford Burnham Prebys adding six scientists in hopes of launching new era of collaboration - Vimarsana News

La Jolla's Sanford Burnham Prebys adding six scientists in hopes of launching new era of collaboration

The newcomers, brought in with help from a $70 million donation, are versed in different technologies that can be applied to any field, the medical research institute's leader says.

La Jolla's Sanford Burnham Prebys adding six scientists in hopes of launching new era of collaboration - Vimarsana News

La Jolla's Sanford Burnham Prebys adding six scientists in hopes of launching new era of collaboration

The newcomers, brought in with help from a $70 million donation, are versed in different technologies that can be applied to any field, the medical research institute's leader says.

This sugar kills honeybees—it could also help - Vimarsana News

This sugar kills honeybees—it could also help

Research from Sanford Burnham Prebys and the Osaka International Cancer Institute has shed new light on the anti-cancer properties of mannose, a sugar that is crucial to many physiological processes in humans and is also known to inhibit the growth of cancer cells.

Pumping the brakes on autoimmune disease - Vimarsana News

Pumping the brakes on autoimmune disease

A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.